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The present study investigated the eﬀects of the antioxidants trolox and dithiothreitol (DTT) on mouse Locus coeruleus (LC)
neurons. Electrophysiological measurement of action potential discharge and whole cell current responses in the presence of each
antioxidant suggested that there are three neuronal subpopulations within the LC. In current clamp experiments, most neurons
(55%; 6/11) did not respond to the antioxidants. The remaining neurons exhibited either hyperpolarization and decreased ﬁring
rate (27%; 3/11) or depolarization and increased ﬁring rate (18%; 2/11). Calcium and JC-1 imaging demonstrated that these
eﬀects did not change intracellular Ca2+ concentration but may inﬂuence mitochondrial function as both antioxidant treatments
modulated mitochondrial membrane potential. These suggest that the antioxidant-sensitive subpopulations of LC neurons may
be more susceptible to oxidative stress (e.g., due to ATP depletion and/or overactivation of Ca2+-dependent pathways). Indeed it
may be that this subpopulation of LC neurons is preferentially destroyed in neurological pathologies such as Parkinson’s disease.
If this is the case, there may be a protective role for antioxidant therapies.
1.Introduction
Oxidative stress in neurons arises because of an imbalance
between free radical production and antioxidant control.
This process leads to cell damage and, when severe, can
triggerapoptosisornecrosis[1].Indeed,suchoxidativestress
may initiate certain neuropathologies such as Alzheimer’s
and Parkinson’s disease whereby oxidative damage to
biomolecules causes cellular dysfunction and neuronal death
[1, 2].
The exact mechanisms whereby healthy neurons become
sensitive to oxidative stress are unknown, and it is also
unclear whether antioxidant treatments limit the spread of
oxidative damage. For example, it has been reported that
varying levels of oxidants can modulate ion channels and
consequently eﬀect important neuronal functions such as
pacemaking [3–5]. Thus, antioxidant treatments have been
developed and used and have indeed had beneﬁcial eﬀects in
preventing or slowing the onset of neurological disease [6].
Antioxidants may modulate transcription factors that
ultimately lead to oxidative stress [7]. On the other hand,
it has been demonstrated that molecules that were thought
to be antioxidants due to their antioxidant capacity in vitro
(such as vitamin A and retinoids) have diﬀerent eﬀects in
living organisms (in vivo) as they can increase oxidative
damage to biomolecules and generate oxidative stress [8–
10]. In fact free radicals are crucial components of many
intracellular signalling pathways (for a review see [11]),
and an exaggerated decrease in their levels could lead to
undesired cellular events. Thus, many factors contribute to
the varied eﬀectiveness of antioxidants in both human and2 Oxidative Medicine and Cellular Longevity
animal trials including diﬀerences in dose and timing of
antioxidant administration.
The present paper explores the eﬀect of two diﬀerent
antioxidants (Trolox and DTT) on pacemaking in Locus
coeruleus (LC) neurons. These antioxidants can chelate dif-
ferent reactive species. Both compounds are membrane per-
meable, so they can easily access intracellular compartments.
Trolox is a water-soluble vitamin E analogue with a broad
antioxidant spectrum [12], whereas DTT is a reducing agent
that acts on thiol (–SH) groups [13]. Here, we demonstrate
that LC neurons exhibit three diﬀerent types of electrophys-
iological responses to these antioxidants. We believe these
responses may represent three neuronal populations that
have diﬀerential sensitivity to free radicals and are involved
in the massive loss of LC neurons observed in pathologies
such as Parkinson’s disease.
2.ExperimentalProcedures
2.1. Preparation of Brain Slices. All procedures used in this
study were approved by the University of Newcastle Animal
Care and Ethics Committee. Brain slices containing the LC
were prepared from Swiss mice (P7–12, both sexes) rendered
unconscious with Ketamine (100mg/kg i.p.) according to a
previous established protocol [14]. Mice were decapitated,
and the brain was rapidly removed and immersed in ice-
cold “modiﬁed sucrose ringer” containing (in mM): 25
NaHCO3, 11 Glucose, 235 Sucrose, 2.5 KCl, 1 NaH2PO4,
1M g C l 2,a n d2 . 5C a C l 2, bubbled with 95% O2/5% CO2
[15]. The cerebellum and brain stem were isolated and slices
(270–300µm thick) were cut with a vibrating tissue slicer
(Leica VT1000S). Slices were kept in a recovery chamber
(containing ACSF) at room temperature and high oxygen
for 1.5–2h before experiments commenced. The slice con-
taining the LC was identiﬁed and transferred to a recording
bath where it was visualized with an upright microscope
(OlympusBX50)andsuperfusedwithartiﬁcialcerebrospinal
ﬂuid (ACSF) containing (in mM): 120 NaCl, 25 NaHCO3,
11 Glucose, 2.5 KCl, 1 NaH2PO4,1M g C l 2 and 2.5 CaCl2,
constantly bubbled with 95% O2/5% CO2.L Cn e u r o n sw e r e
visualized using infrared video microscopy with diﬀerential
interference contrast optics and identiﬁed according to their
large size and location near the ventrolateral border of the
fourth ventricle [16]. Most experiments were performed
on neurons in slices, whereas our Ca2+ imaging and JC-1
experiments used isolated LC neurons.
2.2. Preparation of Fresh Dissociated LC Neurons. Neurons
were isolated using an adapted protocol according to [17].
Brainsliceswerecutusingthesameprotocoldescribedabove
in “Preparation of brain slices” and allowed to recover for 1h
intherecoverychamber.SliceswerethenplacedintheACSF-
containing recording chamber, and neurons were dissociated
and isolated using a custom-made vibrating device. This
instrument dissociated neurons by vibrating a ﬁne glass
electrode with a sealed tip just above the tissue surface. This
method usually provided about 10 healthy neurons per slice.
After isolation, neurons were left for 15min to settle on the
glass bottom of the recording chamber before gentle ACSF
perfusion was commenced.
2.3. Electrophysiology. Electrophysiological recordings were
made using the whole cell attached voltage clamp or current
clamp recording modes (Axopatch-1C ampliﬁer) with data
sampledat100kHzandlow-passﬁlteredat5kHz.Electrodes
had resistance ranging from 1.8 to 2.5 MΩ.N e u r o n s
were considered to be adequately voltage clamped when
no unclamped spikes were observed during voltage ramp
application [14, 16].
2.4. Solutions and Pharmacology. To avoid perfusion-
associated washout during whole cell recording, we used the
same experimental protocol as described previously [16]. In
brief, 10s after intracellular access was obtained, the ﬁrst
voltage protocol was applied, with the treatment perfusion
started immediately using a rapid exchange (>95% change
over time ∼2s) local-perfusion system [18]. The second
voltage protocol was then applied 180s after commencement
of treatment. Total incubation time for voltage clamp exper-
iments was 180s; the incubation time for other experiments
is indicated in the respective ﬁgures. Tetrodotoxin (TTX;
1µM)wasadded to theperfusateto block voltage-dependent
Na+ channels when step pulse protocols were applied. The
standard internal pipette solution contained (in mM): 135K
methylsulphate, 8 NaCl, 10 HEPES, 2 Mg2ATP, 0.3 Na3GTP,
0.1 EGTA, pH: 7.3. The standard external solution used was
ACSF. All experiments were carried out at 33 ±2◦C.
2.5. Acquisition and Analysis. Data were acquired using
Axograph 4.8 software (ITC-16 interface and a Mac G4
computer) and analysed using Axograph X 1.1.0 software.
Input resistance, cell capacitance, and series resistance were
measured by the software according to the response to a
−5mV pulse delivered shortly after obtaining the whole cell
recording mode. A correction of −8.5mV, calculated using
JPCalc[19],wasappliedtoaccountforthejunctionpotential
between ACSF and K methyl sulphate in the recording
pipette. I-V plots were constructed from depolarizing pulse
protocol recordings. Individual currents were normalised
to cell size based on the whole cell capacitance to obtain
current density values (pA/pF). Current density values were
multiplied by 100 to normalise values to the measured
current. Recordings obtained by ramp and depolarizing
pulse protocols were ﬁltered at 1kHz using Axograph X
software prior to analysis.
2.6. Measurement of Cytosolic Ca2+ and Mitochondrial Mem-
brane Potential (Ψm). Relative intracellular [Ca2+]o rΨm
was measured in freshly dissociated LC neurons. After
isolation (Methods), LC neurons were incubated in ACSF
at room temperature containing the ﬂuophores 10µM
Oregon green/AM for 45min or 5µg/mL JC-1 for 1h [20].
The recording chamber containing the isolated and loaded
neurons was then placed on the stage of a Nikon TE200
inverted microscope connected to a BIORAD 1000 confocal
scannersystem.Theisolatedneuronswereviewedwitha60XOxidative Medicine and Cellular Longevity 3
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Figure 1: Impact of Trolox treatment on pacemaker activity in LC neurons. (a) Table demonstrating the eﬀect of 100µM Trolox on the
spontaneous ﬁring of LC neurons and comparison of values obtained for action potentials (APs) before (ACSF) and 180s after 100µM
Trolox treatment (n = 11 for spontaneous ﬁring and n = 23 for AP comparison). (b) Comparison of the waveshape of averaged APs before
(ACSF)and180safterapplicationof100µMTroloxinACSF(n = 23).Hyperpolarizinggroupwasexcludedfromcomparisondemonstrated
in a and b due to lack of APs at 180s treatment. (c) and (d) Recordings demonstrating opposite eﬀects induced by 100 µM Trolox which
in a small number of cases depolarized neurons and increased ﬁring (c) or hyperpolarized neurons which led to abolition of AP ﬁring (d)
(n = 11). AP ﬁring recommenced in response to depolarization induced by current injection (d, Arrow).
water immersion objective. ACSF was perfused for at least
10min before experiments commenced. The Oregon green
ﬂuophore was excited using a 488nm 20mW Argon laser
with intensity set to 3% and recordings made using a 522nm
emission ﬁlter. JC-1 experiments were made using the Argon
laser set to 1% intensity with a ﬁlter combination of 488nm
for excitation and 522nm for emission to record the green
ﬂuorescence and 514nm for excitation and 585nm for
emission to record the red ﬂuorescence. Relative ﬂuorescence
plots were analysed oﬄine using ImageJ software.
2.7.Statistics. A lldataar ep r ese nt edasmean±SEM.Graph-
Pad Prism 4.02 was used to prepare graphics. Statistical
analysis was performed with SPSS version 17.0 using one-
way ANOVA.
3. Results
3.1. Eﬀect of Trolox and DTT on Spontaneous Firing and
Voltage-Dependent Currents of LC Neurons. We ﬁrst exam-
ined the eﬀects of antioxidants on spontaneous ﬁring in LC
neurons. Application of 100µM Trolox had no signiﬁcant
eﬀect on 6 of 11 neurons (Figure 1(a)). Curiously, under
the same conditions, 2 neurons increased their ﬁring rate
(Figures 1(a) and 1(c)) and 3 neurons exhibited strong
hyperpolarization, which abolished spontaneous ﬁring. In
such cases ﬁring could be reinstated by repolarizing the
membrane potential via current injection (Figures 1(a)
and 1(d)). Comparison of averaged action potentials (APs)
from test (100µM Trolox) and control (ACSF) neurons
showed that there were no diﬀerences in AP shape after
180s of treatment (Figures 1(a) and 1(b)). The electro-
physiological properties of neurons that did not respond
and those that hyperpolarized were compared to examine
whether the hyperpolarizing neurons were damaged. This
comparison showed there were no diﬀerences in resting
membrane potential, input resistance, ﬁring frequency,
and after hyperpolarization amplitude. This indicates that
the hyperpolarizing neurons were not simply damaged or
unhealthy neurons (See Supplementary Table in Supplemen-
tary Material available online at doi:10.1155/2012/820285).4 Oxidative Medicine and Cellular Longevity
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Figure 2: Eﬀect of Trolox treatment in voltage-dependent currents evoked by ramps and pulses. (a) Representative recording of the currents
evoked by depolarizing ramps showing the current evoked in ACSF (control solution; solid black line) and the inward (solid light grey)
and outward (dashed grey) currents evoked at 180s after 100µM Trolox application (n = 14). (b) I-V plot for the currents presented in
(a). (c) Mean diﬀerential (i.e., Trolox-control) with records obtained 180s after rapid application of Trolox showing the inward (solid light
grey, 8 of 14 neurons) and outward (dashed grey, 6 of 14 neurons) currents. (d), (e), and (f) were performed in 1µM TTX background. (d)
Representative depolarizing pulse-evoked diﬀerential currents obtained by taking the currents in test solution (i.e., 100µM Trolox + 1µM
TTX) and subtracting the corresponding currents in control (i.e., 1µM TTX) 180s after Trolox application. (e) Averaged I-V plot showing
the currents evoked by pulses for control (1µM TTX—solid black) and the inward (solid light grey) and outward (dashed grey) currents
after 180s of 100µM Trolox application. (f) Mean diﬀerential I-V plots (i.e., Trolox—TTX) inward (solid light grey, 6 of 8 neurons) and
outward (dashed grey, 2 of 8 neurons) after 180s application of 100µM Trolox. Graph shows mean ± SEM with n = 8 for (d), (e) and (f).
Voltage-dependent currents were ﬁrst investigated using
depolarizing ramps (slope of 40mV/s) that were designed
to mimic the natural depolarization during the interspike
interval(see[16]).Intheseexperiments(n = 14LCneurons)
Trolox induced a heterogeneous response (Figure 2(a))w i t h
8 neurons presenting a diﬀerential outward current followed
by an inward current at depolarized potentials. In contrast,
the remaining 6 neurons only exhibited a diﬀerential out-
ward current (Figures 2(b) and 2(c)). The second protocol
applied voltage steps designed to rapidly activate/deactivate
a broad range of ionic channels. When this protocol was
applied to neurons held at a hyperpolarized potential of
−88mV, similar results were observed, but in this case, more
polarizedtowardstheinwardcurrent(6of8neurons,Figures
2(d) to 2(f)). Importantly, the step pulse protocols only
generated either an outward or inward current (Figure 2(f)),
versus the presence of both currents for ramp protocols
(Figure 2(c)). These results indicate that a mix of diﬀerent
voltage-dependentchannelsaredirectlymodulatedbyTrolox
and/or by reactive species chelated by this antioxidant, and
this eﬀect is heterogeneous within the population of LC
neurons.
Dithiothreitol (DTT; 1mM) also produced varied ef-
fects on spontaneous ﬁring activity of 19 LC neurons
(Figure 3(a)). AP ﬁring was not signiﬁcantly altered in 10
neurons and was abolished in 4 due to marked hyperpolar-
ization (Figure 3(c)), and 3 neurons ceased AP ﬁring with no
apparent hyperpolarization (Figures 3(a) and 3(d)). A small
portion of the neurons (2/19) increased their AP ﬁring rate
after depolarization (2 of 19; Figure 3(a)). AP comparison
demonstrated no diﬀerences in AP shape (Figure 3(b))a s
was the case for Trolox.
The voltage-dependent current responses that were ob-
served after DTT application were more heterogeneous thanOxidative Medicine and Cellular Longevity 5
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Figure 3: Impact of DTT treatment in the pacemaker process of LC neurons. (a) Table demonstrating the eﬀect of 1mM DTT in the
spontaneous ﬁring of LC neurons and comparison of values obtained for AP before (ACSF) and 180s after 1mM DTT treatment (n = 19 for
spontaneous ﬁring and n = 28 for AP comparison). (b) Averaged APs demonstrating comparison before (ACSF) and after 180s after 1mM
DDT treatment (n = 28). Hyperpolarizing group was excluded from comparison demonstrated in (a) and (b) due to lack of APs at 180s
treatment. (c) and (d), Example for recordings demonstrating the two minor eﬀects induced by 1mM DTT where neurons hyperpolarized
and ceased ﬁring (c) and stopped ﬁring without hyperpolarization (d) (n = 19).
those for Trolox application. Application of depolarizing
ramps to 9 LC neurons indicated that 7 exhibited a large
inward current at depolarized potentials with minimal if
any initial outward current, and 2 neurons exhibited only
outward currents (Figures 4(a) to 4(c)). Voltage step pro-
tocols applied to further 10 LC neurons produced the
same characteristic depolarization-induced responses with
5 exhibiting inward and 5 exhibiting outward diﬀerential
currents (Figures 4(d) to 4(f)). The size of the currents
induced by both voltage ramp and step protocols during
DTT treatment was larger than the currents induced by
Trolox treatment (compare Figures 2(c) and 2(f) with
Figures 4(c) and 4(f)).
3.2. Eﬀect of Trolox and DTT Cotreatment with the Mitochon-
drialProtonophoreCCCPduringRamp-ElicitedCurrents. We
next investigated a role of mitochondria in the antioxidant
actions as these organelles are the main source of reactive
oxygen species in neurons and also play an important role in
Ca2+ buﬀering [21]. To do this, we perturbed mitochondrial
metabolism using the mitochondrial protonophore carbonyl
cyanide m-chlorophenylhydrazone (CCCP) without and
with cotreatment with Trolox or DTT.
Ramp protocols were used as they can reveal voltage-
dependent currents, including those that ﬂow during the
interspike interval [16]. CCCP (1µM) induced an initial
diﬀerentialoutward(upto ∼−20mV)followedbyaninward
current during the ramp depolarization (Figure 5). Cotreat-
ment with Trolox (100µM) caused a small reduction in
the CCCP-induced diﬀerential outward current between
membrane potentials ∼−40mV to ∼−30mV (Figure 5(a)).
DTT cotreatment in contrast had a more profound impact
on the CCCP-induced diﬀerential outward current. It par-
tially reversed the outward current and reduced it to less
than half at its peak (Figure 5(b)). DTT co-treatment also
shifted the reversal potential from ∼80mV to ∼−60mV,
suggesting recruitment of diﬀerent channels and/or mod-
ulation of the channel’s selectivity to ions. These results6 Oxidative Medicine and Cellular Longevity
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Figure 4: Eﬀect of DTT treatment on voltage-dependent currents evoked by ramps and pulses. (a) Representative recording of the currents
evoked by depolarizing ramps showing the current evoked in ACSF (control solution; solid black line) and the inward (solid light grey)
and outward (dashed grey) currents evoked at 180s after 1mM DTT application (n = 9). (b) I-V plot for the currents presented in a. (c)
Mean diﬀerential (i.e., DTT-control) with records obtained 180s after rapid application of DTT showing the inward (solid light grey, 7 of 9
neurons) and outward (dashed grey, 2 of 9 neurons) currents. (d), (e), and (f) were performed in 1µM TTX background. (d) Representative
depolarizingpulse-evokeddiﬀerentialcurrentsobtainedbytakingthecurrentsintestsolution(i.e.,1mMDTT+1µMTTX)andsubtracting
the corresponding currents in control (i.e., 1µMT T X )1 8 0sa f t e rD T Ta p p l i c a t i o n .( e )A v e r a g e dI-V plot showing the currents evoked by
pulses for control (1µM TTX—solid black) and the inward (solid light grey) and outward (dashed grey) currents after 180s of 1mM DTT
application.(f) Mean diﬀerential I-V plots (i.e., DTT—TTX) inward (solid light grey, 5 of 10 neurons) and outward (dashed grey, 5 of 10
neurons) after 180s application of 1mM DTT. Graph shows mean ± SEM with n = 10 for (d), (e), and (f).
suggest that the antioxidants Trolox and DTT can aﬀect mi-
tochondrial function either directly or by altering existing
neuronal free radicals.
3.3. Impact of Trolox and DTT Treatment on Cytosolic Ca2+
and Mitochondrial Membrane Potential under Control Con-
ditions and When Mitochondrial Function Is Impaired. Due
to the heterogeneous nature of the responses produced by
the two antioxidant treatments, we next investigated if the
activation of diﬀerent currents was related to the cytosolic
Ca2+ concentration ([Ca2+]c) in both control conditions
and those where mitochondrial function was impaired.
Figure 6(a) demonstrates that under control conditions,
neither Trolox or DTT treatments were able to increase
[Ca2+]c, suggesting that Ca2+-activated pathways are not
involved in the induction/modulation of ionic currents
by these antioxidants. When CCCP was added to impair
mitochondrial function, Trolox (100µM) caused a further
enhancement of the CCCP-induced increase in [Ca2+]c
(Figure 6(b)). In contrast, cotreatment with DTT (1mM)
had no impact on the CCCP-induced increase in [Ca2+]c
(Figure 6(b)). The consequences of the Trolox-induced
increase in [Ca2+]c are unclear given that Trolox was less
eﬀective than DTT in modulating CCCP-related voltage
dependent currents (Figure 5(a)).
Given that mitochondrial function is generally depen-
dent on mitochondrial membrane potential (Ψm) [22], weOxidative Medicine and Cellular Longevity 7
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Figure 5: Eﬀect of Trolox and DTT treatment on ramp-evoked currents when mitochondrial membrane potential was impaired with CCCP.
(a) and (b), Mean diﬀerential I-V plots (i.e., Antioxidants-control) demonstrating the impact of 100µM Trolox (a) and 1mM DTT (b)
cotreatments with 1µM CCCP. Graph shows mean ± SEM with n = 13 for (a) and n = 6 for (b).
investigated whether antioxidant treatments were able to
modulate Ψm. Application of CCCP (1µM) reduced Ψm
(Figure 6(c)). Trolox (100µM) or DTT (1mM) also reduced
Ψm to an extent that was indistinguishable from that
produced by impairing mitochondrial function with CCCP
alone (Figure 6(c)). Application of the antioxidants together
withCCCPappearedtobesynergisticasitcausedaprofound
decrease Ψm, with the eﬀect of being most pronounced for
DTTwherea ∼70%reductioninΨmoc curr ed(Figure 6(c)).
Importantly, ﬂuorescence levels partially recovered to the
same levels after 10min of washout for both antioxidants
in control and/or impaired conditions (Figure 6(c)). Taken
together, these results suggest that mitochondria could
be involved in the currents induced by Trolox and DTT
treatments, but such actions are unlikely to be dependent on
[Ca2+]c.
4. Discussion
Many neuronal populations in the CNS are spontaneously
active, including nuclei such as the LC and Substantia nigra
(SN) [23, 24]. Such sustained AP ﬁring is tightly controlled
and, given that nuclei such as the LC project widely over the
brain [25], has major implications for brain function.
Free radicals and oxidative stress are known to be
involved in the initiation and/or progression of a variety of
neurological conditions, such as Alzheimer’s and Parkin-
son’s diseases [26–28], and disturbances in mitochondrial
metabolism seem to be a key event in the occurrence of
suchpathologies[29].Here,wedemonstratethatantioxidant
treatment of LC neurons, a neuronal population that is
suggested to be involved in progression of many neurological
diseases [30, 31], produced a heterogeneous response on
the pacemaking activity in these neurons. Our results
indicate that within the LC there is a subpopulation of
neurons, which are more sensitive to free radical content
and consequent modulation of the pacemaker activity. This
opens the possibility that this neuronal subpopulation is
particularly vulnerable and likely to undergo apoptosis or
necrosis during the onset of speciﬁc neurological diseases.
The LC is the largest concentration of noradrenergic
neurons in the brain, and it projects to and releases nora-
drenaline across a multitude of brain regions [32, 33]. LC
neuron involvement in neurological pathologies, especially
Parkinson’s disease (PD), has been proposed because of
the high levels of LC neuron degeneration observed in PD
patients and because the LC plays a fundamental role in the
early stages of the disease [31, 34]. Further support for this
hypothesis is provided by the fact that lesions to LC neurons
increase the sensitivity of SN neurons to a range of insults
[35, 36] and that simultaneous partial destruction of SN and
LC neurons slows recovery in animal models of Parkinson’s
disease [30]. Furthermore, pharmacological stimulation of
LCneuronsimpartssomeresistancetoSNneuronsinanimal
models; Parkinson’s disease [37] and genetically modiﬁed
animals with increased noradrenergic innervation appear
to be relatively immune to insults on SN neurons [38].
Therefore neuronal death in the LC may be a primary factor
in the onset of PD with the consequent loss of noradrenergic
signalling contributing to the loss of dopaminergic neurons
in the SN. The fact that oxidative stress is one of the main
causes of neuronal death in PD [39] makes the ﬁnding
that there are subpopulations of LC neurons that are highly
sensitive to free radicals of considerable interest.
Our results indicate that both Trolox and DTT induce
heterogeneous responses in LC neuronal pacemaking (Fig-
ures 1–4), suggesting a diﬀerential sensitivity to antioxidants
(or free radical content) in neuronal subpopulations within
the LC. The majority of the neurons exhibited no detectable
alteration in their ﬁring rates (Figures 1(a) and 3(a)). How-
ever, Trolox and DTT revealed two other responses and by8 Oxidative Medicine and Cellular Longevity
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Figure 6: Eﬀect of Trolox and DTT treatment in [Ca2+]c and Ψm in control and impaired conditions. (a) Graph demonstrating that both
antioxidants did not impact on [Ca2+]c in control conditions (n = 5 for both). (b) Graph demonstrating that 100µM Trolox co-treatment
with 1µM CCCP increased [Ca2+]c and 1mM DDT did not eﬀect the normal CCCP-induced increase in [Ca2+]c (n = 6 for Trolox n = 5f o r
DTT cotreatments, and n = 7 for CCCP by itself). (c) JC-1 ﬂuorescence demonstrating the impact of Trolox and DTT in Ψmi nc o n t r o la n d
impaired (1µM CCCP cotreatment) conditions (n = 8 for Trolox and n = 9f o rD T Tb yt h e m s e l v e s ;n = 12 for Trolox and n = 10 for DTT
cotreatments; n = 9 for CCCP by itself). All graphs show mean ± SEM.
inference neuronal subpopulations: the ﬁrst featured hyper-
polarization and slowing down or cessation of pacemaking
activity, whereas the second caused depolarization and an
increase in ﬁring rate (Figures 1 and 3). These observations
are surprising given that LC neurons have generally been
considered to be fairly homogeneous with respect to their
electrophysiological properties, and previous results from
our group detected no electrophysiological diﬀerences in
the neuronal population on which our experiments were
made [14, 16, 40]. Voltage clamp experiments conﬁrmed
the heterogeneity we observed in our experiments on LC
neurons, as application of the antioxidants also revealed
two types of responses when ramps or pulses were applied
(Figures 2 and 4). Another important ﬁnding came from our
Ca2+ imaging experiments where, in contrast, application of
antioxidants produced no change in [Ca2+]c (Figure 6(a)).
This suggests that the eﬀects we observed were caused by
changes in the neuronal free radical content and not by
changes in [Ca2+]c. Trolox treatment had a small impact
on voltage-dependent currents (Figure 5(a)) however DTT
treatment had a profound impact. DDT partially reversed
the currents induced by CCCP coapplication (Figure 5(b))
and this eﬀect was unlikely to be mediated by [Ca2+]c
(Figure 6(b)). A role for mitochondria was indicated as the
antioxidants altered Ψm when applied alone or combined
with CCCP (Figure 6(c)).Oxidative Medicine and Cellular Longevity 9
The ﬁnding of two neuronal subpopulations within LC
that are responsive to antioxidant treatment may be of con-
siderable importance for our understanding of the environ-
ment and physiological conditions that lead to development
of neurological diseases. It is diﬃcult to delineate which
subpopulation will be most adversely aﬀected by changes
in free radical content. The subpopulation that responded
to antioxidants with hyperpolarization will be protected by
antioxidants,aspacemakingandhenceﬁringratewouldslow
down or stop, thus saving energy and accelerating recovery
time in cases of hypoxia [41]. Abolition of ﬁring would also
prevent activation of voltage-dependent Ca2+ channels and
the subsequent increase in [Ca2+]c. This would slow activity
in all Ca2+-dependent pathways.
Control of [Ca2+]c is of fundamental importance given
apoptotic and/or necrotic pathways can be initiated by
uncontrolled increases in [Ca2+]c [42, 43]. In contrast,
the neuronal subpopulation where antioxidants produced
depolarization and elevated ﬁring rates would be stressed by
such treatment. We do not know the mechanism whereby
some cells respond with inward or outward currents fol-
lowing antioxidant application. However, if these actions
were due to altering free radical content, then “mopping up”
free radicals may not necessarily protect cells. Given that
speciﬁc neurological pathologies have been associated with
an increase in free radicals, then it highlights the fact that
antioxidant treatments may need to be carefully evaluated.
In summary, our ﬁndings indicate that there is a small
neuronal subpopulation within LC that responds to antiox-
idants, and, on the basis that this is caused by altering free
radicals,membersofthissubpopulationmaybemoresubject
to apoptosis or necrosis. We believe that the results presented
here represent an important step for our understanding of
how free radicals contribute to neuropathologies (such as
LC loss in Parkinson’s diseases) and suggest that antioxidant
therapies must be carefully evaluated before administration.
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